[OC-05] Gene & Cell Therapy for Neurological Diseases

[OC-05-3] GM2ガングオシドーシスの遺伝子治療

^○伊藤 孝司^1,5, 辻 大輔¹, 大西 恭哉¹, 渡邊 綾佑², 浅井 克仁^3,5, 村松 慎一^4,5 (1.徳島大学大学院医歯薬学研究部創薬生命工学分野, 2.徳島大学薬学部, 3.株式会社遺伝子治療研究所, 4.自治医科大学　神経学部門, 5.AMED 橋渡し研究戦略的推進プログラム（シーズB）事業)

Education
1977-1981 Kyoto Univ. B.S. - Pharmacy
1981-1983 Sch. of Pharmaceut. Sci., Kyoto Univ., M.S. - Pharmaceut. Sci.
1983-1986 Grad. Sch. of Pharmaceut. Sci., The Tokyo University Ph.D.

Professional Carrier:
1986-1999 Research Scientist (1995~1999 Chief Scientist)
The Tokyo Metropol. lnstit. of Medi. Sci., Tokyo, Japan
1999- Professor (2009- Director), Dept. of Medicin. Biotechnol.,
Inst. for Medicin. Res., Grad. Scl. of P harmaceut. Sci.,Tokushima Univ., Japan

Grants and Awards:
2004-2008 JST CREST Group Research Director
2009-2013 NIBIO Subdirector
2010-2014 MAFF Promot. of Appl. Res. for Agrihealth Sci. PT Subdirector
2013-2015 MEXT KAKENHI (Scientific Research on Innovative Areas)
2014-2016 MEXT KAKENHI (Basic Research, B)
2016-2017 AMED ACT-MS
2017- AMED TR-SPRINT

Research fields: Lysosomal storage diseases, Molecular pathogenesis and therapy